EQT to Buy Qiagen for $12 Billion
EQT will acquire Qiagen for $12 billion, an offer described as barely above one rejected by shareholders in 2020.
Story updates
10:16:34 AM UTC
SquawkNews
EQT's offer for European biotech Qiagen is expected to go through, according to Berenberg analysts. "Overall, we think that shareholders are likely to accept the deal, and we note that the structure is designed to secure it: EQT needs only 50% plus one share," Berenberg writes in a research note. T…
By Aimee DonnellanEQT will buy Qiagen for $12 bln, whose kits trace diseases and help police solve crimes. It’s barely more than an offer shareholders rejected back in 2020. Yet the Swedish buyer will need to grow beyond current forecasts and crank up margins to get a decent return.Full view will b…